Cargando…
Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration
Glaucoma is a multifactorial disease that is conventionally managed with treatments to lower intraocular pressure (IOP). Despite these efforts, many patients continue to lose their vision. The degeneration of retinal ganglion cells (RGCs) and their axons in the optic tract that characterizes glaucom...
Autores principales: | Al Hussein Al Awamlh, Sara, Wareham, Lauren K., Risner, Michael L., Calkins, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124776/ https://www.ncbi.nlm.nih.gov/pubmed/33925119 http://dx.doi.org/10.3390/ijms22094672 |
Ejemplares similares
-
Astrocyte Networks as Therapeutic Targets in Glaucomatous Neurodegeneration
por: Boal, Andrew M., et al.
Publicado: (2021) -
The Neurovascular Unit in Glaucomatous Neurodegeneration
por: Wareham, Lauren K., et al.
Publicado: (2020) -
Dysfunctional cGMP Signaling Leads to Age-Related Retinal Vascular Alterations and Astrocyte Remodeling in Mice
por: Holden, Joseph M., et al.
Publicado: (2022) -
The Role of Mitophagy in Glaucomatous Neurodegeneration
por: Stavropoulos, Dimitrios, et al.
Publicado: (2023) -
cGMP signaling: a potential therapeutic target for neurodegeneration in glaucoma?
por: Holden, Joseph M., et al.
Publicado: (2022)